Long-acting PDE5 inhibitor tadalafil prevents early doxorubicin-induced left ventricle diastolic dysfunction in juvenile mice: potential role of cytoskeletal proteins.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Canadian Journal of Physiology and Pharmacology

• Publication date

  2017-02-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1139/cjpp-2016-0551PMID 28238269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in desmin expression in patients with cardiac diastolic dysfunction and preserved or reduced ejection fraction.

  2015cited by this paper
• Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up

  2014cited by this paper
• Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

  2014cited by this paper
• Right Versus Left Ventricular Failure: Differences, Similarities, and Interactions

  2014cited by this paper
• Recent Insights in the Paracrine Modulation of Cardiomyocyte Contractility by Cardiac Endothelial Cells

  2014cited by this paper
• Extracellular matrix remodeling in early cardiac fibrosis and diastolic dysfunction

  2013cited by this paper
• Beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy.

  2013cited by this paper
• Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions A Scientific Statement From the American Heart Association

  2013cited by this paper
• A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat

  2013cited by this paper
• Chronic inhibition of cGMP‐specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure

  2013cited by this paper
• Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis.

  2013cited by this paper
• Sildenafil Prevents and Reverses Transverse-Tubule Remodeling and Ca2+ Handling Dysfunction in Right Ventricle Failure Induced by Pulmonary Artery Hypertension

  2012cited by this paper
• Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection.

  2012cited by this paper
• Application of Echocardiography on Transgenic Mice with Cardiomyopathies

  2012cited by this paper
• Molecular and Cellular Basis for Diastolic Dysfunction

  2012cited by this paper
• Mechanisms and management of doxorubicin cardiotoxicity

  2011cited by this paper
• Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load

  2011cited by this paper
• Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor.

  2010cited by this paper
• Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction

  2010cited by this paper
• Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-Induced Cardiomyopathy without Interfering with Chemotherapeutic Effect

  2010cited by this paper
• Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain.

  2009cited by this paper
• cGMP-Hydrolytic Activity and Its Inhibition by Sildenafil in Normal and Failing Human and Mouse Myocardium

  2009cited by this paper
• Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

  2009cited by this paper
• Cdc42GAP, reactive oxygen species, and the vimentin network.

  2009cited by this paper
• Long-Term Survivors of Childhood Cancers in the United States

  2009cited by this paper
• Anthracycline cardiotoxicity: from bench to bedside.

  2008cited by this paper
• Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group

  2008cited by this paper
• Molecular basis of diastolic dysfunction.

  2008cited by this paper
• Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography.

  2008cited by this paper
• Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

  2008cited by this paper
• Dissociation of Crk-associated substrate from the vimentin network is regulated by p21-activated kinase on ACh activation of airway smooth muscle.

  2007cited by this paper
• Prevention of anthracycline-induced cardiotoxicity in children: the evidence.

  2007cited by this paper
• Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility

  2007cited by this paper
• Exposure to anthracyclines during childhood causes cardiac injury.

  2006cited by this paper
• Critical Role of Vimentin Phosphorylation at Ser-56 by p21-activated Kinase in Vimentin Cytoskeleton Signaling*

  2006cited by this paper
• Current perspectives in diastolic dysfunction and diastolic heart failure

  2006cited by this paper
• New molecular mechanism in diastolic heart failure.

  2006cited by this paper
• Phosphodiesterase-5 Inhibitor Sildenafil Preconditions Adult Cardiac Myocytes against Necrosis and Apoptosis

  2005cited by this paper
• Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

  2005cited by this paper
• Phosphodiesterase-5 Inhibition With Sildenafil Attenuates Cardiomyocyte Apoptosis and Left Ventricular Dysfunction in a Chronic Model of Doxorubicin Cardiotoxicity

  2005cited by this paper
• Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle.

  2004cited by this paper
• The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage

  2004cited by this paper
• Cellular Basis of Abnormal Calcium Transients of Failing Human Ventricular Myocytes

  2003cited by this paper
• Sarcoplasmic reticulum Ca2+ and heart failure: roles of diastolic leak and Ca2+ transport.

  2003cited by this paper
• PDE-5 Inhibition and Sexual Response: Pharmacological Mechanisms and Clinical Outcomes

  2002cited by this paper
• Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study.

  2001cited by this paper
• Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.

  2000cited by this paper
• Comparison of four echocardiographic techniques for measuring left ventricular ejection fraction.

  2000cited by this paper
• Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995.

  1999cited by this paper
• Epidemiology of anthracycline cardiotoxicity in children and adults.

  1998cited by this paper
• Role of myosin heavy chain composition in kinetics of force development and relaxation in rat myocardium

  1998cited by this paper
• Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function.

  1998cited by this paper
• Effect of Right Ventricular Pressure on the End‐ Diastolic Left Ventricular Pressure*dash;Volume Relationship before and after Chronic Right Ventricular Pressure Overload in Dogs without Pericardia

  1984cited by this paper
• A New, Simplified and Accurate Method for Determining Ejection Fraction with Two‐dimensional Echocardiography

  1981cited by this paper

• Cancer therapy-related cardiovascular aging: mechanisms, monitoring, and intervention strategies

  2026cites this paper
• Pharmacotherapy for Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Childhood Cancer Survivors

  2023cites this paper
• Beyond hypertension: Diastolic dysfunction associated with cancer treatment in the era of cardio-oncology.

  2022cites this paper
• Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin

  2022cites this paper
• Enzymes as Biocatalysts: Review on Investigations on Synthesis, Mechanism, Kinetics, Applications and Potential

  2021cites this paper
• Doxorubicin Paradoxically Ameliorates Tumor-Induced Inflammation in Young Mice

  2021cites this paper
• Pluronic F127/Doxorubicin microemulsions: Preparation, characterization, and toxicity evaluations

  2021cites this paper
• Copolymer/graphene oxide nanocomposites as potential anticancer agents

  2020cites this paper
• Insight into the Pro-inflammatory and Pro-Fibrotic Role of Macrophage in Heart Failure with Preserved Ejection Fraction.

  2020cites this paper
• PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular Dysfunction

  2019cites this paper
• Effects of Resistance Exercise Training on Doxorubicin-Induced Cardiotoxicity

  2018cites this paper
• Examination of the effects of different phosphodiesterase type 5 enzyme inhibitors on the isolated rat myometrium contraction

  2018cites this paper
• Regulation of Transplanted Cell Homing by FGF1 and PDGFB after Doxorubicin Myocardial Injury

  2018cites this paper
• Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity

  2018cites this paper
• PDE5 inhibitors, erectile dysfunction and beyond : How, sometimes, indications are the consequences of marketing strategies and/or serendipity

  2017cites this paper